These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6860527)

  • 1. The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.
    Serlin MJ; Orme ML; MacIver M; Green GJ; Sibeon RG; Breckenridge AM
    Br J Clin Pharmacol; 1983 May; 15(5):519-27. PubMed ID: 6860527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of long-acting propranolol ('Inderal' LA) in the management of elderly hypertensive patients.
    Hamdy C; Tovey D; Baber NS; McAinsh J
    Eur J Clin Pharmacol; 1982; 22(5):379-81. PubMed ID: 7117349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol LA and ambulatory blood pressure.
    Mann S; Craig MW; Balasubramanian V; Raftery EB
    Br J Clin Pharmacol; 1980 Nov; 10(5):443-7. PubMed ID: 7437256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-acting propranolol on blood pressure and heart rate in hypertensive Chinese.
    Oh VM; Chia BL; Taylor EA
    Br J Clin Pharmacol; 1985 Aug; 20(2):144-7. PubMed ID: 4041332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting propranolol (Inderal LA): pharmacokinetics, pharmacodynamics and therapeutic use.
    Mishriki AA; Weidler DJ
    Pharmacotherapy; 1983; 3(6):334-41. PubMed ID: 6361703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a once daily long-acting formulation of propranolol with conventional propranolol given twice daily in patients with mild to moderate hypertension.
    Douglas-Jones AP
    J Int Med Res; 1979; 7(3):221-3. PubMed ID: 378731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience.
    Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
    Am J Med; 1987 Dec; 83(6B):15-9. PubMed ID: 3332574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of propranolol and propranolol LA in hypertension using 24-hr noninvasive blood pressure monitoring.
    Rustin MH; Coomes EN
    Postgrad Med J; 1983 Dec; 59(698):770-4. PubMed ID: 6686326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics and pharmacological actions of a long-acting formulation of propranolol.
    Ohashi K; Ebihara A; Kondo K; Usami M
    Arzneimittelforschung; 1984; 34(4):507-12. PubMed ID: 6378211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a long-acting form of propranolol and conventional propranolol in the treatment of hypertension in elderly patients.
    Khan AU
    J Int Med Res; 1987; 15(3):128-33. PubMed ID: 3301452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of long acting propranolol. Implications for therapeutic use.
    Nace GS; Wood AJ
    Clin Pharmacokinet; 1987 Jul; 13(1):51-64. PubMed ID: 3304770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.
    Watson RG; Bastain W; Larkin KA; Hayes JR; McAinsh JA; Shanks RG
    Br J Clin Pharmacol; 1987 Oct; 24(4):527-35. PubMed ID: 3689632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of long-acting propranolol 60-mg capsules: a comparative evaluation.
    Marino MR; Dey M; Garg DC; Jallad NS; Dorick DM; Martinez JJ; Weidler DJ
    J Clin Pharmacol; 1987 Nov; 27(11):885-91. PubMed ID: 3429696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of Half-Inderal LA and Inderal LA in the treatment of hypertension in elderly subjects.
    Datta SR
    Br J Clin Pract; 1989 Mar; 43(3):102-8. PubMed ID: 2692687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol.
    Garg DC; Jallad NS; Mishriki A; Chalavarya G; Kraml M; Fencik M; Weidler DJ
    J Clin Pharmacol; 1987; 27(5):390-6. PubMed ID: 3693583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations.
    Carter BL; Gersema LM; Williams GO; Schabold K
    Pharmacotherapy; 1989; 9(1):17-22. PubMed ID: 2646619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol in the control of blood pressure: a dose-response study.
    Serlin MJ; Orme ML; Baber NS; Sibeon RG; Laws E; Breckenridge A
    Clin Pharmacol Ther; 1980 May; 27(5):586-92. PubMed ID: 6102895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose administration of propranolol in hypertension: a comparison of two formulations using clinic and home blood pressure measurements.
    Vandongen R; Beilin LJ; Lalor C; Wall BP
    Aust N Z J Med; 1982 Oct; 12(5):473-7. PubMed ID: 6758744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol in cardiac arrhythmias: a comparative study of the conventional and long-acting formulations.
    Kubik MM; Gill B; Dawes PM
    Curr Med Res Opin; 1986; 10(4):215-20. PubMed ID: 3780285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic comparison of two doses of long acting propranolol (80 and 160 mg) in healthy subjects.
    Flouvat B; Berlin I; Cournot A; Robinet D; Duchier J; Sarmini H; Rossi A
    Br J Clin Pharmacol; 1989 May; 27(5):539-45. PubMed ID: 2757878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.